Peripheral clearance of amyloid β peptide by complement C3-dependent adherence to erythrocytes

Brain deposits of amyloid β peptide (Aβ) have been a diagnostic hallmark of Alzheimer's disease (AD) for nearly a century. Recent studies have demonstrated that Aβ is also present in peripheral blood. Here, we present evidence that circulating Aβ42 is subject to complement C3b-dependent adheren...

Full description

Saved in:
Bibliographic Details
Published inNeurobiology of aging Vol. 27; no. 12; pp. 1733 - 1739
Main Authors Rogers, Joseph, Li, Rena, Mastroeni, Diego, Grover, Andrew, Leonard, Brian, Ahern, Geoffrey, Cao, Phillip, Kolody, Heather, Vedders, Linda, Kolb, William P., Sabbagh, Marwan
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.12.2006
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Brain deposits of amyloid β peptide (Aβ) have been a diagnostic hallmark of Alzheimer's disease (AD) for nearly a century. Recent studies have demonstrated that Aβ is also present in peripheral blood. Here, we present evidence that circulating Aβ42 is subject to complement C3b-dependent adherence to complement receptor 1 (CR1) on erythrocytes, a classical set of mechanisms by which pathogens and proteins recognized as foreign are cleared from the bloodstream. Levels of Aβ42 targeted by this pathway differ significantly in AD compared to mild cognitive impairment and nondemented elderly controls.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0197-4580
1558-1497
1558-1497
DOI:10.1016/j.neurobiolaging.2005.09.043